Effect of TGF-β1 on the expression of IL-12, IL-15, IL-18, IL-4 and IL-10 in heart transplantation rejection in rats

Abstract

To investigate the effect of TGF-β1 on the expressions of IL-12, IL-15, IL-18, IL-4 and IL-10 in heart transplantation rejection in rats, a model of rat cervical heterotopic heart transplantation was set up and the model rats were randomly divided into three groups: control group, transplant group and TGF-β1 group. The mRNA expression levels of IL-12, IL-15, IL-18, IL-4 and IL-10 were determined by RT-PCR at the 5th day after the transplantation. The mRNA expression levels of IL-12, IL-15, IL-18 were increased obviously and those of IL-4, IL-10 were significantly decreased in the transplant group as compared with the control group (P<0.01). In the TGF-β1 group, the mRNA expression levels of IL-12, IL-15, IL-18 were significantly decreased and those of IL-4, IL-10 were significantly increased as compared with the transplant group (P<0.01). The immunosuppressive effect of TGF-β1 on heart transplantation rejection was related to its inhibition of the expressions of Th1-type cytokines (IL-12, IL-15, IL-18 etc) and its promotion of the expressions of Th2-tpye cytokines (IL-4, IL-10).

Keywords

heart transplantation / TGF-β1 / rejection / cytokines

References

[1] TashiroH., ShinozakiK., YahataH.. Prolongation of liver allograft survival after interleukin-10 gene transduction 24–48 hours before donation. Transplantation, 2000, 70(2): 336-339

[2] CerwenkaA., SwainS. L.. TGF-betal: immunosuppressant and viability factor for T lympocytes. Microbes Infect, 1999, 1(15): 1291-1296

[3] PrudG. J., PiccirilloC. A.. The inhibitory effects of transforming growth factors-beta-1 (TGF-betal) in autoimmune diseases. J Autoimmun, 2000, 14(1): 23-42

[4] ChenZ.. A new technique of cervical heterotopic heart transplantation in mice. Transplantation, 1991, 52: 1099

[5] HutchiusonI. V., PracicaV., PerreyC., et al.. Cytokine gene polymorphisms and relevance to forms of rejection. Transplant Proc, 1999, 31: 734-736

[6] VermaN., HeX. Y., ChenJ., et al.. Interleukin 12 delays allograft rejection: effect mediated via nitric oxide. Transplant Proc, 2001, 33(1–2): 416-417

[7] WasowskaB. A., ZhengX. X., StromT. B., et al.. Adjunctive rapamycin and CsA treatment inhibits monocyte/macrophage associated cytokines/chemokines in sensitized cardiac graft recipients. Transplantation, 2001, 71(8): 1179-1183

[8] BaanC. C., KnoopC. J., HolwegC. T., et al.. The macrophage-derived T-cell growth factor interleukin-15 is present in interleukin-2-independent rejection after clinical heart and liver transplantation. Transplant Proc, 1999, 31(7): 2726-2728

[9] AlvarezC. M., FernandezD., BuilesM., et al.. Intragraft cytokine expression in heart transplants with mild or no histological rejection. Clin Transplant, 2001, 15(4): 228-235

[10] TasakiK., YoshidaY., MaedaT., et al.. Protective immunity is induced in murine colon carcinoma cells by the expression of interleukin-12 or interleukin-18, which activate type 1 helper T cells. Cancer Gene Ther, 2000, 7(2): 247-254

[11] ReddyP., TeshimaT., HildebrandtG., et al.. Interleukin 18 preserves a perforin-dependent graft-versus-leukemia effect after allogeneic bone marrow transplantation. Blood, 2002, 100(9): 3429-3431

[12] ItoK., TakaishiH., JinY.. Staphylococcal enterotoxion B stimulates expansion of autoreactive T cells that induce apoptosis in intestinal epithelial cells: Regulation of autoreactive response by IL-10. J Immunol, 2000, 164: 2994-3001